RecruitingEarly Phase 1NCT05771675
Simvastatin Treatment to Improve Patient-reported Outcomes in Patients With Chronic Pancreatitis
Sponsor
Cedars-Sinai Medical Center
Enrollment
90 participants
Start Date
Oct 24, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of this pilot study to examine the feasibility and acceptability of simvastatin in adults with Recurrent Acute Pancreatitis (RAP) and Chronic Pancreatitis (CP).
Eligibility
Min Age: 18 YearsMax Age: 75 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a drug called Placebo and a drug called Simvastatin for people with chronic pancreatitis and recurrent acute pancreatitis. The study is currently recruiting participants at 5 locations. People eligible for this study include aged 18 Years to 75 Years.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGSimvastatin
40Mg Oral Tablet
DRUGPlacebo
Matching Simvastatin Placebo tablet
Locations(5)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05771675
Related Trials
Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
NCT0665158026 locations
Malabsorption Blood Test (MBT) to Determine Exocrine Pancreatic Function and Related Quality of Life in Chronic Pancreatitis
NCT074185932 locations
QST Study: Predicting Treatment Response in Chronic Pancreatitis Using Quantitative Sensory Testing
NCT034343922 locations
Pancreatic Quantitative Sensory Testing (P-QST) to Predict Treatment Response for Pain in Chronic Pancreatitis
NCT049966283 locations
Evaluation of Pirfenidone as a Novel Therapeutic Strategy Against Recurrent Acute Pancreatitis.
NCT062531172 locations